Impact BioMedical Inc. Announces Pricing of Initial Public Offering
September 16, 2024 10:24 ET
|
Impact BioMedical, Inc.
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the...
Veea Inc. and Plum Acquisition Corp. I Announce Closing of Business Combination
September 16, 2024 08:30 ET
|
Veea Inc.
NEW YORK and SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Veea Inc. (“Veea” or the “Company”), a first-to-market pioneer in hyperconverged multiaccess networks and AI-driven edge computing, and...
Prairie Provident Announces Loan Amendments and $13.2 Million Equity Rights Offering With $12 Million of Committed Participation
September 13, 2024 19:13 ET
|
Prairie Provident Resources Inc.
CALGARY, Alberta, Sept. 13, 2024 (GLOBE NEWSWIRE) -- September 13, 2024 – Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) announces an agreement to extend the...
Future Vision II Acquisition Corp. Announces the Closing of its Initial Public Offering and Full Exercise of Underwriter’s Over-Allotment Option to Purchase Additional Units
September 13, 2024 12:31 ET
|
FUTURE VISION II ACQUISITION CORP.
NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Future Vision II Acquisition Corp. (NASDAQ: FVNNU) (“Future Vision”) today announced the closing of its initial public offering of 5,750,000 units,...
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
September 12, 2024 22:37 ET
|
Zenas BioPharma
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development...
Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering
September 12, 2024 21:15 ET
|
Bicara Therapeutics Inc.
BOSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients...
MBX Biosciences Announces Pricing of Initial Public Offering
September 12, 2024 19:11 ET
|
MBX Biosciences, Inc.
CARMEL, Ind., Sept. 12, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Murano Announces Closing of U.S.$300 Million Offering of Senior Secured Notes
September 12, 2024 18:21 ET
|
Murano Global Investments Plc.
LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- MURANO GLOBAL INVESTMENTS PLC (“Murano” or the “Company”) (NYSE: MRNO), announced today the closing of an offering of U.S.$300,000,000 aggregate principal...
Future Vision II Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering
September 11, 2024 17:15 ET
|
FUTURE VISION II ACQUISITION CORP.
NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Future Vision II Acquisition Corp. (NASDAQ: FVNNU, the “Company”) announced today that it priced its initial public offering of 5,000,000 units at $10.00...
Viper Energy Launches Offering of Class A Common Stock
September 11, 2024 16:31 ET
|
Viper Energy, Inc.
MIDLAND, TEXAS, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”) announced today the launch of an underwritten public offering of 8,500,000 shares of its Class A common...